Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
Umeclidinium + Vilanterol vs Tiotropium + Olodaterol Head to Head Study
Comparative Efficacy of Once-Daily Umeclidinium + Vilanterol vs Tiotropium + Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study
Head to Head Study:
Umeclidinium + Vilanterol vs Tiotropium + Olodaterol
August 2018 – PH/UCV/0022/18
DISCLOSURES:
- These podcasts are organized and funded by GSK
- These podcasts contain promotional content
- No part of these podcasts can be copied or retrieved without prior written permission from GSK
- Prescribing information may be accessed via GSKpro.ph
- This podcast features voice talents portraying doctors. The module and the script used were created by a GSK Medical Affairs Manager, who is employed by GSK on a full-time basis and does not hold shares in GSK.
Prescribing Information
FOR HEALTHCARE PROFESSIONALS ONLY
Full Prescribing Information available upon request .
Trademarks are owned by or licensed to the GSK group of companies
© 2018 GSK group of companies
Kindly forward all adverse events and product complaints to
GSK Philippines via these contact details:
Adverse events: ph.safety@gsk.com or 0917 889 0640
Product complaints: 0917 889 7050.
